BB19519-NCT05617625

Dynamic List Information
Dynamic List Data
Study Title
A Phase II Trial of CD34+ Enriched Transplants From HLA-Compatible Related or Unrelated Donors for Treatment of Patients With Myelodysplastic Syndrome
Sponsor Name
Baptist Health Herbert Wertheim Cancer Institute
NCT Number
NCT05617625
IDE Number
BB19519
CMS Approval Date
2026-08-18
Category
B